News

Video

Florez Focuses on Patient-Centered NSCLC Biomarker Testing

Related Videos
Kimmie Ng, MD, MPH
Marina Chiara Garassino, MD
Related Content
Idoroenyi Amanam, MD
October 9th 2024

Myelofibrosis Treatment Advances Rely on Past Developments to Drive Future Innovation

D. Ross Camidge, MD, PhD; Jeanne Fourie Zirkelbach, PhD, clinical pharmacologist, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, FDA
October 9th 2024

PRO Research Is Key for a Patient-Focused Oncology Pharmacology Career: With D. Ross Camidge, MD, PhD, and Jeanne Fourie Zirkelbach, PhD

Eric Kumar Singhi, MD, of MD Anderson Cancer Center
October 9th 2024

Exploring Facets of Both the SCLC and NSCLC Therapeutic Landscapes

Updated VISION Trial Data Showcase the Efficacy of Tepotinib in MET + NSCLC: With Martin Dietrich, MD
October 7th 2024

Updated VISION Trial Data Showcase the Efficacy of Tepotinib in MET + NSCLC: With Martin Dietrich, MD

FDA
October 9th 2024

FDA Grants Orphan Drug Designation to Namodenoson for Pancreatic Cancer

LBL-024 for Extrapulmonary Neuroendocrine Carcinoma | Image Credit: © catalin - stock.adobe.com
October 9th 2024

LBL-024 Receives Breakthrough Therapy Designation in China for Extrapulmonary Neuroendocrine Carcinoma